Reported secondary malignancies after APL-directed therapy
| Secondary malignancies . | Recommended screening . |
|---|---|
| t-MNs (MDS, AML) | CBC with peripheral smear review |
| Breast cancer | Annual mammogram |
| Colon cancer | Colonoscopy at appropriate interval |
| Melanoma | Biannual skin examination |
| Prostate cancer | Discussion of prostate-specific antigen monitoring |
| Soft-tissue sarcoma | None |
| Secondary malignancies . | Recommended screening . |
|---|---|
| t-MNs (MDS, AML) | CBC with peripheral smear review |
| Breast cancer | Annual mammogram |
| Colon cancer | Colonoscopy at appropriate interval |
| Melanoma | Biannual skin examination |
| Prostate cancer | Discussion of prostate-specific antigen monitoring |
| Soft-tissue sarcoma | None |
MDS, myelodysplastic syndrome.